Double maintains 1 strategies that include APGE - Apogee Therapeutics, Inc.
SeekingAlpha
Apogee's strong financial position, with $731.1 million in cash, funds operations through Q1 2028, de-risking its ambitious pipeline development in...
Yahoo
We recently published a list of the 12 Best IPO Stocks to Buy in 2025. In this article, we are going to take a look at where Apogee Therapeutics, Inc. (NASDAQ:APGE) stands against other best IPO stocks to buy in 2025. On February 25, Hamilton Lane co-CEO Erik Hirsch joined ‘Closing Bell Overtime’ on CNBC […]
Yahoo
On Monday, Apogee Therapeutics, Inc. (NASDAQ:APGE) released interim Phase 1 results from its first-in-human trial of APG990. APG990 interim Phase 1 pharmacokinetic (PK) data showed a half-life of approximately 60 days across doses tested. Key data from the 40-healthy subject trial showed: APG990 demonstrated a potential best-in-class PK profile, including a half-life of approximately 60 days, supporting the potential for every three- and six-month maintenance dosing. The PK profile supports the
Yahoo
Accelerated execution of Phase 2 APEX clinical trial for APG777, with Part A over-enrolled and Part B initiated ahead of schedule; topline Part A 16-week data expected mid-2025 APG279 (APG777 + APG990) Phase 1b head-to-head study vs. DUPIXENT supported by positive APG990 interim Phase 1 results, which exceeded trial objectives and demonstrated potential for three- and six-month dosing in combination with APG777; APG279 readout expected in second half of 2026 $731.1 million cash, cash equivalents
Yahoo
Interim Phase 1 results for APG990, a novel half-life extended OX40L antibody, exceeded trial objectives and demonstrated an approximately 60-day half-life APG279 (APG777 + APG990) Phase 1b head-to-head study vs. DUPIXENT supported by successful completion of preclinical combination toxicology studies and positive APG990 interim Phase 1 results; trial planned to initiate this year with readout expected in second half of 2026 Webcast to be held today at 8:30 a.m. ET SAN FRANCISCO and BOSTON, Marc
Yahoo
We recently published a list of the 10 Best Small-Cap Stocks to Buy Now. In this article, we are going to take a look at where Apogee Therapeutics, Inc. (NASDAQ:APGE) stands against the other small-cap stocks. The S&P 500 index has reached its all-time highs, achieving returns of over 20% for the second consecutive year […]
Current Value
$32.181 Year Return
Current Value
$32.181 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -37.19% | $422.73M | 1.43% |
VIXY | -34.76% | $195.31M | 0.85% |
TAIL | -30.67% | $103.42M | 0.59% |
USDU | -12.19% | $217.39M | 0.5% |
UUP | -9.53% | $243.64M | 0.77% |
CTA | -8.70% | $985.77M | 0.76% |
IVOL | -8.56% | $487.86M | 1.02% |
FXY | -7.15% | $745.99M | 0.4% |
KCCA | -5.56% | $94.69M | 0.87% |
SHYM | -4.73% | $306.46M | 0.35% |
TBLL | -4.20% | $2.47B | 0.08% |
TFLO | -3.74% | $7.08B | 0.15% |
TPMN | -3.32% | $31.05M | 0.65% |
ULST | -3.11% | $624.22M | 0.2% |
GBIL | -2.70% | $6.27B | 0.12% |
BILZ | -2.70% | $807.76M | 0.14% |
BSMW | -2.36% | $101.91M | 0.18% |
XONE | -2.09% | $626.56M | 0.03% |
CGSM | -1.20% | $641.00M | 0.25% |
SMB | -0.97% | $263.96M | 0.07% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 62.30% | $4.65B | 0.35% |
IBB | 56.50% | $5.06B | 0.45% |
PBE | 56.41% | $204.38M | 0.58% |
GNOM | 53.92% | $43.88M | 0.5% |
ARKG | 50.50% | $898.81M | 0.75% |
IWC | 50.26% | $709.33M | 0.6% |
IWO | 50.06% | $10.07B | 0.24% |
BBH | 49.25% | $321.29M | 0.35% |
VTWO | 48.55% | $10.25B | 0.07% |
IWM | 48.34% | $57.88B | 0.19% |
FBT | 48.34% | $964.65M | 0.56% |
PTH | 48.20% | $97.93M | 0.6% |
KAPR | 48.15% | $163.40M | 0.79% |
KJUL | 47.90% | $128.70M | 0.79% |
PINK | 47.68% | $131.13M | 0.5% |
SCHA | 47.38% | $14.62B | 0.04% |
NUSC | 47.02% | $996.11M | 0.31% |
KOMP | 46.90% | $1.86B | 0.2% |
KJAN | 46.72% | $292.10M | 0.79% |
VBK | 46.52% | $15.96B | 0.07% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SHYD | 0.27% | $316.64M | 0.35% |
EQLS | -0.36% | $4.99M | 1% |
STPZ | -0.41% | $452.30M | 0.2% |
CARY | 0.48% | $347.36M | 0.8% |
UGA | -0.51% | $71.61M | 0.97% |
UNG | -0.54% | $374.88M | 1.06% |
XHLF | -0.80% | $1.07B | 0.03% |
TBIL | -0.82% | $5.43B | 0.15% |
BILS | -0.86% | $3.85B | 0.1356% |
SMB | -0.97% | $263.96M | 0.07% |
FTSD | 1.13% | $219.33M | 0.25% |
CGSM | -1.20% | $641.00M | 0.25% |
DBE | 1.73% | $48.57M | 0.77% |
JMST | 1.86% | $3.45B | 0.18% |
KMLM | 2.03% | $203.74M | 0.9% |
XONE | -2.09% | $626.56M | 0.03% |
MEAR | 2.21% | $939.76M | 0.25% |
BSMW | -2.36% | $101.91M | 0.18% |
BILZ | -2.70% | $807.76M | 0.14% |
GBIL | -2.70% | $6.27B | 0.12% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FMTO | -16.61% | $299.10K | -99.74% | 0.00% |
K | -13.47% | $28.41B | +48.48% | 2.76% |
PULM | -11.57% | $19.72M | +150.00% | 0.00% |
STG | -11.29% | $24.92M | -45.45% | 0.00% |
CBOE | -9.61% | $22.52B | +20.49% | 1.13% |
VHC | -9.03% | $37.17M | +53.05% | 0.00% |
WBA | -7.78% | $9.32B | -39.61% | 6.90% |
UUU | -7.08% | $3.96M | +3.32% | 0.00% |
VSTA | -7.07% | $389.63M | +27.56% | 0.00% |
KO | -7.05% | $307.40B | +22.56% | 2.76% |
RILY | -6.57% | $90.58M | -86.04% | 16.35% |
KR | -6.52% | $45.09B | +23.59% | 1.84% |
LITB | -5.88% | $32.92M | -60.89% | 0.00% |
BNED | -5.83% | $300.70M | -87.61% | 0.00% |
VSA | -5.41% | $3.58M | -81.08% | 0.00% |
VZ | -4.42% | $184.54B | +10.10% | 6.17% |
NEUE | -4.25% | $52.97M | +0.99% | 0.00% |
AGL | -4.24% | $2.34B | +14.75% | 0.00% |
SYPR | -3.43% | $36.37M | -6.51% | 0.00% |
EZPW | -3.37% | $860.34M | +44.33% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MCK | -0.01% | $86.39B | +31.81% | 0.40% |
PEP | -0.05% | $198.06B | -14.08% | 3.76% |
FATBB | -0.14% | $44.48M | -35.36% | 16.80% |
COKE | 0.14% | $12.16B | +70.79% | 0.42% |
TSN | -0.19% | $21.14B | +4.78% | 3.27% |
PPC | -0.27% | $12.54B | +69.61% | 0.00% |
PDCO | -0.37% | $2.73B | +21.41% | 2.49% |
PRPO | 0.47% | $8.51M | -14.94% | 0.00% |
T | -0.69% | $192.30B | +64.26% | 4.16% |
DESP | 0.86% | $1.59B | +55.93% | 0.00% |
ED | 1.05% | $39.56B | +23.93% | 3.05% |
IMNN | 1.09% | $12.43M | -46.54% | 0.00% |
AWK | 1.18% | $28.49B | +25.32% | 2.09% |
EXC | 1.36% | $46.44B | +26.10% | 3.36% |
CVS | -1.37% | $87.75B | +1.27% | 3.83% |
HEES | 1.44% | $3.33B | +46.68% | 1.21% |
AEP | 1.68% | $58.23B | +27.44% | 3.46% |
CME | 1.75% | $94.25B | +24.84% | 4.04% |
COR | -1.79% | $55.14B | +21.51% | 0.76% |
HIHO | 1.84% | $6.25M | -35.16% | 8.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SYRE | 52.32% | $736.34M | -67.40% | 0.00% |
ATXS | 49.40% | $227.99M | -62.63% | 0.00% |
ELVN | 48.36% | $809.06M | -21.68% | 0.00% |
CRNX | 48.04% | $2.71B | -34.72% | 0.00% |
KRYS | 47.66% | $4.77B | -4.96% | 0.00% |
KYMR | 47.54% | $1.57B | -32.21% | 0.00% |
IDYA | 46.67% | $1.47B | -60.09% | 0.00% |
OCUL | 46.36% | $1.13B | -11.01% | 0.00% |
XENE | 46.35% | $2.40B | -23.97% | 0.00% |
DYN | 45.57% | $796.37M | -72.77% | 0.00% |
NTLA | 45.06% | $767.06M | -69.47% | 0.00% |
IMNM | 44.47% | $617.35M | -65.50% | 0.00% |
QTRX | 44.40% | $201.70M | -71.69% | 0.00% |
RCUS | 44.32% | $865.78M | -50.66% | 0.00% |
ACLX | 44.11% | $3.25B | +1.86% | 0.00% |
CLDX | 43.61% | $1.12B | -57.10% | 0.00% |
DNLI | 43.00% | $1.84B | -30.45% | 0.00% |
NEO | 42.98% | $1.20B | -33.85% | 0.00% |
PLAB | 42.65% | $1.15B | -34.67% | 0.00% |
BEAM | 42.57% | $1.54B | -40.34% | 0.00% |